Literature DB >> 15007221

Recurrent subependymoma treated with radiosurgery.

Robert D Ecker1, Bruce E Pollock.   

Abstract

PURPOSE: Subependymomas are rare, slow-growing intracranial neoplasms of the subependymal matrix. We document a successful case of radiosurgical treatment of a multiply recurrent subependymoma.
MATERIALS AND METHODS: A nineteen-year-old male developed a recurrent fourth ventricular subependymoma after 6 resections, fractionated radiation therapy (50.4 Gy) and chemotherapy. In addition, a lesion consistent with a cavernous malformation (CM) was noted adjacent to the tumor within the previously irradiated region.
RESULTS: Stereotactic radiosurgery was performed covering both the subependymoma and the presumed CM. Fifty-four months after radiosurgery, both lesions had decreased in size and the patient remained neurologically unchanged.
CONCLUSIONS: Subependymoma may be added to the list of primary glial neoplasms that have been successfully managed with stereotactic radiosurgery. Also, we add a case of presumed CM following radiation therapy to the literature. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15007221     DOI: 10.1159/000076662

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  3 in total

1.  Multiple supratentorial subependymomas causing obstructive hydrocephalus.

Authors:  Jason Schroeder; Devon LeFever; Pouya Entezami; Robert E Mrak
Journal:  BMJ Case Rep       Date:  2017-06-03

Review 2.  Surgical management and long-term outcome of intracranial subependymoma.

Authors:  Adithya Varma; David Giraldi; Samantha Mills; Andrew R Brodbelt; Michael D Jenkinson
Journal:  Acta Neurochir (Wien)       Date:  2018-06-18       Impact factor: 2.216

3.  Intraparenchymal subependymoma: Case report and literature review.

Authors:  Othavio Gomes Lopes; Felipe Calmon Du Pin Almeida; Gustavo Augusto Porto Sereno Cabral; Rodrigo Dias Guimaraes; Ruy Castro Monteiro da Silva Filho; Jose Alberto Landeiro
Journal:  Surg Neurol Int       Date:  2021-04-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.